Literature DB >> 22364898

Postoperative lymphocysts after lymphadenectomy for gynaecological malignancies: preventive techniques and prospects.

Aziz Achouri1, Cyrille Huchon, Anne-Sophie Bats, Cherazade Bensaïd, Claude Nos, Fabrice Lécuru.   

Abstract

Postoperative lymphocyst formation is an insufficiently recognised complication of lymphadenectomy for gynaecological malignancies. Lymphocysts are collections of lymph organised into cysts that develop in contact with lymphadenectomy compartments. There has been considerable debate about the relevance of lymphocyst prevention using surgical or pharmacotherapeutic methods. Here, we review the available studies about the impact of these methods on the incidence of lymphocysts. This review suggests that several techniques may decrease the incidence of lymphocysts when used in combination. On a literature basis, the peritoneum should be left open over the lymphadenectomy sites at the end of the procedure and drains should not be placed at the end of the procedure. Omentoplasty should be encouraged and further studies are needed to assess the potential benefits of new energies. Postoperative octreotide therapy seems beneficial but the role of this drug in pelvic oncological surgery remains to be determined.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364898     DOI: 10.1016/j.ejogrb.2011.12.021

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  10 in total

1.  What Are the Risk Factors for Lymphocyst Formation Apart From Lymphnode Dissection and Lymphnode Count in Gynecologic Malignancy?

Authors:  A Sahbaz; K Gungorduk; V Gulseren; I A Ozdemir; M Harma; M Harma; M Sancı
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915

Review 2.  Lower extremity edema in patients with early ovarian cancer.

Authors:  Myong Cheol Lim; Jeong Seon Lee; Byung Ho Nam; Sang-Soo Seo; Sokbom Kang; Sang-Yoon Park
Journal:  J Ovarian Res       Date:  2014-03-07       Impact factor: 4.234

3.  Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.

Authors:  Kenji Kuroda; Yasuhiro Yamamoto; Manami Yanagisawa; Akira Kawata; Naoya Akiba; Kensuke Suzuki; Kazutoshi Naritaka
Journal:  BMC Womens Health       Date:  2017-07-25       Impact factor: 2.809

4.  Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study.

Authors:  Yun Hwan Kim; Hyun Joo Shin; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2017-02-28       Impact factor: 4.401

5.  Predictors of Lymphoceles in Women Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecologic Cancer: A Retrospective Cohort Study.

Authors:  Hui-Hua Chen; Wan-Hua Ting; Ho-Hsiung Lin; Sheng-Mou Hsiao
Journal:  Int J Environ Res Public Health       Date:  2019-03-15       Impact factor: 3.390

6.  Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies.

Authors:  Xuegong Ma; Yingmei Wang; Aiping Fan; Mengting Dong; Xin Zhao; Xuhong Zhang; Fengxia Xue
Journal:  Arch Gynecol Obstet       Date:  2018-09-29       Impact factor: 2.344

7.  Polidocanol echosclerotherapy treatment for lymphocele: case report and review.

Authors:  Sergio Quilici Belczak; Gabriela Balarini Figueiredo Lima; Karin Coca Aguilar; Walter Junior Boim de Araujo; Fabiano Luiz Erzinger; Felipe Coelho
Journal:  J Vasc Bras       Date:  2019-12-12

8.  A retrospective study of internal small bowel herniation following pelvic lymphadenectomy for gynecologic carcinomas.

Authors:  Yuji Tanaka; Yusuke Shimizu; Ai Ikki; Kota Okamoto; Atsushi Fusegi; Makoto Nakabayashi; Makiko Omi; Tomoko Kurita; Terumi Tanigawa; Yoichi Aoki; Sachiho Netsu; Mayu Yunokawa; Hidetaka Nomura; Maki Matoda; Sanshiro Okamoto; Kohei Omatsu; Hiroyuki Kanao
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

9.  Bleomycin sclerotherapy for severe symptomatic and persistent pelvic lymphocele.

Authors:  Ana Sofia Fernandes; Antónia Costa; Raquel Mota; Vera Paiva
Journal:  Case Rep Obstet Gynecol       Date:  2014-07-06

10.  Effectiveness of Fibrin Sealant Patch in Reducing Drain Volume after Pelvic Lymph Node Dissection in Women with Gynecologic Malignancy.

Authors:  Hwa Cheong Kim; Chahien Choi; Woo Young Kim
Journal:  Biomed Res Int       Date:  2017-11-27       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.